O
EW icon

OppenheimerFunds’s Edwards Lifesciences EW Stock Holding History

OppenheimerFunds’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$22.3M Sell
349,581
-21,966
-6% -$1.25M 0.03% 504
2018
Q4 		$19M Buy
371,547
+35,142
+10% +$1.78M 0.03% 527
2018
Q3 		$19.5M Sell
336,405
-147,405
-30% -$7.21M 0.02% 589
2018
Q2 		$23.5M Buy
483,810
+26,052
+6% +$1.22M 0.03% 540
2018
Q1 		$21.3M Buy
457,758
+444,009
+3,229% +$19.3M 0.03% 550
2017
Q4 		$517K Sell
13,749
-504,150
-97% -$18.5M ﹤0.01% 1507
2017
Q3 		$18.9M Sell
517,899
-227,757
-31% -$8.69M 0.02% 582
2017
Q2 		$29.4M Sell
745,656
-192,834
-21% -$7.04M 0.04% 434
2017
Q1 		$29.4M Sell
938,490
-465,765
-33% -$14.6M 0.04% 452
2016
Q4 		$43.9M Buy
1,404,255
+531,966
+61% +$17.2M 0.06% 352
2016
Q3 		$35.1M Buy
872,289
+20,019
+2% +$754K 0.04% 415
2016
Q2 		$28.3M Sell
852,270
-480,645
-36% -$16.4M 0.04% 463
2016
Q1 		$39.2M Buy
1,332,915
+465,870
+54% +$12.9M 0.05% 378
2015
Q4 		$22.8M Buy
867,045
+95,325
+12% +$2.48M 0.03% 527
2015
Q3 		$18.3M Buy
771,720
+82,980
+12% +$2M 0.02% 568
2015
Q2 		$16.4M Sell
688,740
-218,460
-24% -$4.93M 0.02% 637
2015
Q1 		$21.5M Buy
907,200
+46,020
+5% +$1.03M 0.02% 575
2014
Q4 		$18.3M Buy
861,180
+144,960
+20% +$2.91M 0.02% 608
2014
Q3 		$12.2M Buy
+716,220
New +$11.3M 0.01% 700

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

OppenheimerFunds's EW Position: Q1 2019 in Review

OppenheimerFunds reduced its Edwards Lifesciences (EW) stake by 5.9% in Q1 2019, selling an estimated $1.25M and leaving 349,581 shares worth $22.3M. The position accounts for 0.03% of the portfolio, ranked #504.

OppenheimerFunds first reported a position in EW in Q3 2014 and has held it in 19 quarters since. The position peaked at $43.9M in Q4 2016. 923 funds tracked by Wall St. Rank hold EW as of Q1 2019.

  • OppenheimerFunds held 349,581 shares of Edwards Lifesciences worth $22.3M as of Q1 2019.
  • OppenheimerFunds sold 21,966 Edwards Lifesciences shares in Q1 2019, an estimated $1.25M.
  • Edwards Lifesciences made up 0.03% of OppenheimerFunds's portfolio in Q1 2019, its #504 holding.
  • OppenheimerFunds first reported a position in Edwards Lifesciences in Q3 2014 and has held it in 19 quarters since.
  • OppenheimerFunds's Edwards Lifesciences position peaked at $43.9M in Q4 2016.
  • 923 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.